LFMD Q2 2018 Earnings — LifeMD, Inc. Revenue & Financial Results | Market Cap Arena

LFMDLifeMD, Inc.

$200M

Q2 2018 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$2M+84.0% YoY

Gross Profit

$2M73.8% margin

Operating Income

-$597,493-29.3% margin

Net Income

-$607,032-29.8% margin

EPS (Diluted)

$-0.07

QoQ Revenue Growth

+26.8%

Cash Flow

Operating Cash Flow

-$294,104

Free Cash Flow

-$294,104

Stock-Based Comp.

$340,395

Balance Sheet

Total Assets

$2M

Total Liabilities

$511,469

Stockholders' Equity

$1M

Cash & Equivalents

$691,169

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$1M	+84.0%
Gross Profit	$2M	$778,172	+93.1%
Operating Income	-$597,493	-$225,477	-165.0%
Net Income	-$607,032	$737,489	-182.3%